NHS England publishes guidance on Flash Glucose Monitors for Type 1 diabetes patients

7 Mar 2019 01:41 PM

Tens of thousands of patients with type 1 diabetes will benefit from life changing glucose monitors on the NHS from next month.

NHS England today published the clinical guidance for the monitors, outlining funding arrangements for local health groups and the criteria for who qualifies for the technology.

From April, the NHS will provide the technology for one in five of those with type 1 diabetes in England. Those who qualify include:

Patients will be able to receive it on prescription from their local GP or diabetes team, helping them to better manage their blood sugar level and NHS England will reimburse local health groups for costs of the wearable sensors.

The pioneering technology should ultimately help people with Type 1 diabetes achieve better health outcomes and benefits for patients include:

Dr Partha Kar, Associate National Clinical Director at Diabetes said: 

“This is an important step forward for the NHS and for people with type 1 diabetes.

“The guidance published today confirms the NHS’ commitment to improving the care of those with type 1 diabetes and signals an end to the variation in availability to the life changing technology.”

JDRF Chief Executive Officer in the UK, Karen Addington said: 

“We are delighted that these new guidelines will effectively end the inequity of access to Flash Glucose Monitoringthat people living with type 1 diabetes have experienced, based simply on where they live in England. JDRF has worked with NHS England and partners to secure this outcome and look forward to supporting the implementation in April.”

Of those with a diagnosis of diabetes, an estimated 260,000 in England have Type 1 diabetes.